Form 4 for INSM INSMED Inc
Accepted 2024-12-20 00:00:00 ET · period of report 2024-12-19 · accession 0001628280-24-052229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $69.91 | -18.8K | 390.5K | -5% | -$1.31M |
| DMI | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $69.92 | -6,830 | 235.5K | -3% | -$477.6K |
| D | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 403.7K | +5% | +$426.8K |
| DI | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| D | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -18.8K | 112.5K | -14% | $0 |
| DI | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -6,830 | 232.3K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-19 | S | D | 5,588 | $70.52 | 384,960 | D By the Katie Procter Dynasty Trust | — | — | (F3) This is the weighted average sales price representing 5,588 shares sold at prices ranging from $70.23 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2024-12-19 | S | D | 1,590 | $70.61 | 233,924 | I | — | — | (F5) This is the weighted average sales price representing 1,590 shares sold at prices ranging from $70.36 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2024-12-19 | S | D | 13,162 | $69.65 | 390,548 | D By the Katie Procter Dynasty Trust | — | — | (F2) This is the weighted average sales price representing 13,162 shares sold at prices ranging from $69.22 to $70.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Common | Common Stock | 2024-12-19 | M | A | 18,750 | $22.76 | 403,710 | D By the Katie Procter Dynasty Trust | — | — | |
| 5 | Common | Common Stock | 2024-12-19 | M | A | 6,830 | $10.85 | 240,754 | I | — | — | |
| 6 | Common | Common Stock | 2024-12-19 | S | D | 5,240 | $69.71 | 235,514 | I | — | — | (F4) This is the weighted average sales price representing 5,240 shares sold at prices ranging from $69.28 to $70.27 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 7 | Derivative | Stock Option (right to buy) | 2024-12-19 | M | D | 18,750 | $0.00 | 112,500 | D By the Katie Procter Dynasty Trust | $22.76 · — to 2025-05-21 | 18,750 Common Stock | (F6) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 8 | Derivative | Stock Option (right to buy) | 2024-12-19 | M | D | 6,830 | $0.00 | 232,290 | I | $10.85 · — to 2026-05-19 | 6,830 Common Stock | (F6) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |